Prinaberel — CAS 524684-52-4

Prinaberel (ERB-041) is a selective estrogen receptor beta (ERβ) agonist investigated for anti-inflammatory and immunomodulatory effects. It has been studied as a potential therapeutic agent in conditions such as rheumatoid arthritis, endometriosis, and inflammatory bowel disease, leveraging ERβ's role in modulating immune responses. Mediocon Inc manufactures Prinaberel API at its GMP-certified facility in Aurangabad, Maharashtra, India.

• Investigational treatment of rheumatoid arthritis and inflammatory joint disease
• Research in endometriosis management via ERβ pathway modulation
• Inflammatory bowel disease research (Crohn's disease, ulcerative colitis)
• Pharmacological research tool for selective ERβ pathway studies

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support